At present, there are more means of hepatitis B treatment and more drugs available for patients to choose from, and doctors can develop individualized antiviral regimens according to each patient’s specific situation. In terms of the clinical results of antiviral treatment, the prognosis of patients has improved greatly compared to before. The progression of hepatitis B to cirrhosis and liver cancer has been slowed down or even blocked, and some patients with early cirrhosis can be reversed, and their quality of life has been significantly improved. However, what many people do not know is that not all hepatitis B patients need antiviral treatment. Hepatitis B is different from hepatitis C. As long as the hepatitis C virus is positive and there are no contraindications to interferon, we advocate active antiviral therapy for all patients, but not for hepatitis B. The timing of antiviral therapy for hepatitis B should be chosen appropriately. The patient should not choose any anti-viral drugs to treat himself, but should communicate with his doctor and follow the doctor’s instructions, and choose the right drug to treat him at the right time. Many patients do not know the timing of antiviral treatment, they take a look at the laboratory test “hepatitis B positive”, they come to the hospital “request” antiviral treatment, or even listen to the advertising, or the so-called family recipes, their own arbitrary treatment, the result spent a lot of The result is that they spend a lot of energy and money, but do not get the results they expect, and may even have drug-related hepatitis or delayed disease. Is the antiviral treatment for hepatitis B effective? Yes! However, if the timing of antiviral treatment is not appropriate, it may bring trouble to the future treatment. If antiviral treatment is chosen at an inappropriate time when liver function is normal and transaminases are not elevated, not only is it not very effective, but when antiviral treatment is really needed, either the virus has mutated or the body has developed drug resistance, and it is difficult for antiviral drugs to have the desired effect.